Skip to main content

Worldwide Alopecia Drugs Industry To 2026 - Featuring Cipla, Micro Labs And Merck Among Otehrs

DUBLIN, Jan. 26, 2022 /PRNewswire/ -- The "Global Alopecia Drugs Market (2021-2026) by Alopecia Types, Drugs, Route of Administration, Gender, Sales Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been...
  • Author:
  • Publish date:

DUBLIN, Jan. 26, 2022 /PRNewswire/ -- The "Global Alopecia Drugs Market (2021-2026) by Alopecia Types, Drugs, Route of Administration, Gender, Sales Channel, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Alopecia Drugs Market is estimated to be USD 869.4 Mn in 2021 and is expected to reach USD 1462.35 Mn by 2026, growing at a CAGR of 10.96%.The major factor contributing to the growth of the alopecia drug market is the rising awareness about alopecia owing to rising stress levels, sedentary lifestyle, hormonal changes, and hereditary conditions. Furthermore, the rise in pollution and the growing geriatric population have increased the cases of hair loss.

In addition, the increasing prevalence of cancer, hypertension, depression, etc., leading to hair loss, has raised the demand for the alopecia drugs market. However, as alopecia is not a life-threatening condition and lacks proper approved treatment, various patients do not opt for the treatment, which has hindered the market. The increasing research and development for novel drug treatment of alopecia are anticipated to drive the market during the forecast period.

The Global Alopecia Drugs Market is segmented based on Alopecia Types, Drugs, Route of Administration, Gender, Sales Channel, and Geography. Company Profiles

Some of the companies covered in this report are Cipla, Sun Pharmaceutical, Ranbaxy, Aurobindo, Accord Healthcare, Taisho Pharmaceutical, etc. Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Why buy this report?

  • The report offers a comprehensive evaluation of the Global Alopecia Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Key Topics Covered: 1 Report Description 2 Research Methodology

3 Executive Summary 4 Market Influencers4.1 Drivers4.1.1 Growing Awareness Regarding Alopecia Drugs 4.1.2 Increasing Prevalence of Diseases and Drugs Inducing Alopecia4.1.3 Rising Geriatric Population and Sedentary Lifestyle 4.2 Restraints4.2.1 High Cost Of Medicine 4.2.2 Stringent Government Regulations 4.3 Opportunities 4.3.1 Ongoing Research and Development in Alopecia Drugs 4.3.2 Increasing Healthcare Expenditure Emerging Countries 4.4 Challenges4.4.1 Adoption of Substitutes4.4.2 Discontinuation and Low Adoption of Treatment 4.5 Trends 5 Market Analysis5.1 Regulatory Scenario5.2 Porter's Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis 6 Global Alopecia Drugs Market, By Alopecia Types6.1 Introduction6.2 Alopecia Areata 6.3 Alopecia Totalis 6.4 Alopecia Universalis 6.5 Cicatricial Alopecia6.6 Traction Alopecia6.7 Tinea Capitis6.8 Androgenetic Alopecia6.9 Anagen Effluvium6.10 Others 7 Global Alopecia Drugs Market, By Drugs7.1 Introduction7.2 Vasodilators (Minoxidil)7.3 5-Alpha Reductase Inhibitors (Finasteride)7.4 Corticosteroids7.5 Others 8 Global Alopecia Drugs Market, By Route of Administration8.1 Introduction8.2 Injectable 8.3 Oral 8.4 Topical 9 Global Alopecia Drugs Market, By Gender9.1 Introduction9.2 Men 9.3 Women 10 Global Alopecia Drugs Market, By Sales Channel10.1 Introduction10.2 Prescriptions10.3 OTC 11 Global Alopecia Drugs Market, By Geography11.1 Introduction11.2 North America11.2.1 US11.2.2 Canada11.2.3 Mexico11.3 South America11.3.1 Brazil11.3.2 Argentina11.3.3 Chile11.3.4 Colombia11.4 Europe11.4.1 UK11.4.2 France11.4.3 Germany11.4.4 Italy11.4.5 Spain11.4.6 Netherlands11.4.7 Sweden11.4.8 Russia11.4.9 Rest of Europe11.5 Asia-Pacific11.5.1 China11.5.2 Japan11.5.3 India11.5.4 Indonesia11.5.5 Malaysia11.5.6 South Korea11.5.7 Australia11.5.8 Sri Lanka11.5.9 Thailand 11.5.10 Rest of APAC11.6 Middle-East and Africa11.6.1 Qatar11.6.2 Saudi Arabia11.6.3 South Africa11.6.4 United Arab Emirates 12 Competitive Landscape12.1 Competitive Quadrant12.2 Market Share Analysis12.3 Strategic Initiatives 12.3.1 M&A and Investments12.3.2 Partnerships and Collaborations12.3.3 Product Developments and Improvements 13 Company Profiles13.1 Cipla 13.2 Sun Pharmaceutical13.3 Micro Labs13.4 Torrent Pharma13.5 Indiabulls Pharmaceutical13.6 Johnson & Johnson13.7 Merck13.8 Kirkland Signature13.9 Histogen13.10 GlaxoSmithKline13.11 L`Oreal13.12 Concert Pharmaceuticals13.13 Aurobindo 13.14 Accord Healthcare 13.15 Ranbaxy 13.16 Taisho Pharmaceutical13.17 Theradome13.18 Intas Pharmaceuticals13.19 Abbott 13.20 Avacor 13.21 Glenmark 14 AppendixFor more information about this report visit https://www.researchandmarkets.com/r/uj4329

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

View original content: https://www.prnewswire.com/news-releases/worldwide-alopecia-drugs-industry-to-2026---featuring-cipla-micro-labs-and-merck-among-otehrs-301467916.html

SOURCE Research and Markets